Price To Earnings Ratio 17.21 | Sector PE 65.59 |
PB Ratio 4.08 | Sector PB 8.92 |
EPS 77.56 | Dividend Yield 1.00 |
Today's Volume 276.400 K | 5 Day Avg. Volume 630.193 K |
PEG Ratio 0.18 | Market Cap. ₹ 24,660.00 Cr. |
Time | NATCOPHARM | VS | Industry |
---|---|---|---|
1 Day | -0.92% | 1.42% | |
1 Week | -0.6% | 1.36% | |
1 Month | 3.91% | -0.56% | |
6 Months | 28.61% | 14.7% | |
1 Year | 81.64% | 46.06% |
Period (Days) | SMA | Indication |
---|---|---|
10 | 1358.66 | Bearish |
20 | 1358.75 | Bearish |
30 | 1360.21 | Bearish |
50 | 1393.7 | Bearish |
100 | 1406.69 | Bearish |
200 | 1226.82 | Bullish |
Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |||||
---|---|---|---|---|---|---|---|---|---|
Operating Activities | 1211.60 | 849.10 | 46.50 | 298.80 | |||||
Investing Activities | -1032.70 | -477.10 | -5.30 | -103.30 | |||||
Financing Activities | -246.90 | -363.00 | 34.80 | -185.70 | |||||
Net Cash Flow | -68.00 | 9.00 | 76.00 | 9.80 |
All Figures in ₹ Cr., unless mentioned otherwise
Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
---|---|---|---|---|---|
NATCO Pharma | -0.92 | -0.6 | 3.91 | 28.61 | 81.64 |
Alembic | 1.92 | -1.81 | 3.67 | -6.7 | -6.7 |
Aurobindo Pharma | 0.55 | -1.52 | -14.58 | -10 | 19.75 |
Fortis Healthcare | 0.83 | 11.39 | 15.86 | 32.89 | 84.42 |
Ajanta Pharmaceuticals | 1.18 | 5.73 | 2.08 | 13.83 | 47.7 |
Natco Pharma Limited is a vertically integrated R&D pharmaceutical company based in India. The company's field of activity is the pharmaceutical business, which includes research and development, production and sale of bulk drugs and ready-made medical preparations. The company produces ready-to-use dosage forms (FDFs), which it sells in India, the US and the rest of the world, and also produces active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic splicing technologies, production of potent APIs and peptides. The company operates in two segments: Pharmaceuticals and Agricultural Chemicals. In the pharmaceutical industry, the Company channels its sales through FDFs and APIs. The agrochemicals segment focuses on specialty products, including pest control.